The Treatment of CAPD Peritonitis with Vancomycin: The Genesis of New Clinical Guidelines
1997; Wiley; Volume: 10; Issue: 3 Linguagem: Inglês
10.1111/j.1525-139x.1997.tb00472.x
ISSN1525-139X
Autores Tópico(s)Nosocomial Infections in ICU
ResumoSeminars in DialysisVolume 10, Issue 3 p. 142-144 The Treatment of CAPD Peritonitis with Vancomycin: The Genesis of New Clinical Guidelines Stephen I. Vas, Stephen I. Vas Departments of Microbiology and Medicine, The Toronto Hospital Western Division and the University of Toronto, Faculty of Medicine, Toronto, Ontario, CanadaSearch for more papers by this author Stephen I. Vas, Stephen I. Vas Departments of Microbiology and Medicine, The Toronto Hospital Western Division and the University of Toronto, Faculty of Medicine, Toronto, Ontario, CanadaSearch for more papers by this author First published: 28 June 2008 https://doi.org/10.1111/j.1525-139X.1997.tb00472.xCitations: 2 M.D., Ph.D. Stephen I. Vas F.R.C.P.(c), Professor of Microbiology and Medicine, The Toronto Hospital Western Division, 399 Bathurst Street, EW 6–522, Toronto, Ontario M5T 2S8, Canada. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Hau T, Ahrenholz DH, Simmons RL: Secondary bacterialperitonitis: The biologic basis of treatment.In: Current Problems in Surgery. Vol 16 No. 10. Year Book Medical Publishers,Inc., Chicago, IL, 1979 Google Scholar 2 Rubin J, Oreopoulos DG, Lio TT, Mathews R, de Veber GA:Management of peritonitis and bowel perforation during chronic peritoneal dialysis.Nephron 10: 220 225, 1976 10.1159/000180605 CASWeb of Science®Google Scholar 3 Antibiotic lavage for peritonitis. Editorial 1979.Brit Med J 103: 691 692, 1979 Google Scholar 4 DeGroc F, Rottembourg J, Jacq D, Jaslier V, N'Guyen J, Legrain M:Les peritonites au cours de la dialyse peritoneal continue ambulatoire.Traitment par lavage ou non? Etude prospective Nephrologie (SWZ) 10: 24 27, 1983 Web of Science®Google Scholar 5 De Tremont JF, Khissi H, Thomas D, Tolain M, Lawrence G, Coevoet B, Fournier A, Orfica J:Traitment des peritonites ou dialyse peritoneal. Comparison entrelavage continue avec machine et lavage intermittent par quatre sac/jour de DPCA.Pathol Biol(Paris) 10: 544 547, 1983 Google Scholar 6 Stephen RL, Kablitz C, Kitahara M, Welson JA, Duffin DP, Kolff WJ:Peritoneal dialysis: peritonitis: saline iodine flush.Dial Transpl 10: 584 595, 1979 Web of Science®Google Scholar 7 Rubin J, Rodgers WA, Taylor HM, Everett ED, Prowant BF, Fruto LU, Nolph KD:Peritonitis during continuous ambulatory peritoneal dialysis.Ann Intern Med 10: 7 13, 1980 10.7326/0003-4819-92-1-7 Web of Science®Google Scholar 8 Williams P, Khana R, Vas S, Layne S, Pantalony D. Oreopoulos DG: Treatment of peritonitis in patients on CAPD: To lavage or not?Perit Dial Bul 10: 14 17, 1980 Google Scholar 9 Digenis GE, Khanna R, Pierratos A, Vas S:Morbidity and mortality after treatment of peritonitis with prolonged exchanges intraperitoneal antibiotics.Perit Dial Bull 10: 45 46, 1982 Google Scholar 10 Cantaluppi A, Scalamogna A, Guerra L, Graziani G, Ponticelli C:Treatment of peritonitis in patients on CAPD.Perit Dial Bull 10: 142, 1982 Google Scholar 11 Williams P, Khanna R, Simpson H, Vas SI:Tobramycin blood levels of CAPD patients during peritonitis.Perit Dial Bull 10: 48, 1982 Google Scholar 12 Sewell DL & Golper TA:Stability of antimicrobial agents in peritoneal dialysate.Antimicrob Agents Chemother 10: 528 529, 1982 10.1128/AAC.21.3.528 Web of Science®Google Scholar 13 Manuel MA, Paton TW, Cornish WR:Drugs and peritoneal dialysis.Perit Dial Bull 10: 117 125, 1983 Google Scholar 14 Sewell DL, Golper TA, Brown SD, Nelson E, Knower M, Kimbrough RC:Stability of single and combination antimicrobial agents invarious peritoneal dialysates in the presence of insulin andheparin.Am J Kidney Dis 10: 209 212, 1983 10.1016/S0272-6386(83)80064-X Web of Science®Google Scholar 15 Rubin J, Humphries J, Smith G, Bower J:Antibiotic activity in peritoneal dialysate.Am J Kidney Dis 10: 205 208, 1983 10.1016/S0272-6386(83)80063-8 Google Scholar 16 Bunke CM, Aronoff GR, Luft C:Pharmacokinetics of common antibiotics used in continuous ambulatoryperitoneal dialysis.Amer J Kidney Dis 10: 114 117, 1983 10.1016/S0272-6386(83)80025-0 Google Scholar 17 Peterson PK, Matzke GR, Keane WF:Current concepts in the management of peritonitis incontinuous ambulatory peritoneal dialysis patients.Rev Infec Dis 10: 604 612, 1987 10.1093/clinids/9.3.604 Google Scholar 18 Millikin SP, Matzke GR, Keane WF:Antimicrobial treatment of peritonitis associated with continuousambulatory peritoneal dialysis.Perit Dial Int 10: 252 260, 1991 Web of Science®Google Scholar 19 Keane WF, Everett ED, Fine RN, Golpert T, Vas SI, Peterson PK:CAPD related peritonitis management and antibiotic therapy recommendations.Perit Dial Bull 10: 55 68, 1987 Google Scholar 20 British Society for Antimicrobial Chemotherapy: Diagnosis andmanagement of peritonitis in continuous ambulatory peritonealdialysis: Report of a working party of the British Society forAntimicrobial Chemotherapy. Lancet I. 845 848, 1987 Google Scholar 21 Keane WF, Everett ED, Fine RN, Golpert TA, Vas S, Peterson PK, Gokal R, Matzke GR:Continuous ambulatory peritoneal dialysis(CAPD) peritonitis treatment recommendations.1989 update.Perit Dial Int 10: 247 256, 1989 Web of Science®Google Scholar 22 Keane WF, Everett ED, Golpert TA, Gokal R, Halstenson C, Kawaguchi Y, Riella M, Vas S, Verbrugh HA:Peritoneal dialysisrelated peritonitis treatment recommendations.1993 Update.Perit Dial Int 10: 14 28, 1993 Web of Science®Google Scholar 23 VasSI:Single daily dose of aminoglycosides in the treatmentof CAPD peritonitis.Perit Dial Int 10: 3 s355 s356, 1993 Google Scholar 24 Vas, SI:Treatment of peritonitis.Perit Dial Int 10: 3. 49 55, 1994 Google Scholar 25 Haqqie SS, Bailie GR, Eisele G, Stratton V:Once daily gentamicin and once weekly vancomycin intraperitoneallyto treat CAPD peritonitis.Perit Dial Int 10: 3 S79, 1994 Google Scholar 26 Chadwick D, Turner K, Hair M, McEwen A, Gokal R:Outcome of peritonitis with intraperitoneal (IP) weeklyvancomycin and daily IP Netilmycin.Perit Dial Int 10: 3. S24, 1995 Google Scholar 27 Lye WC, Wong PL, van der Straaten JC, Leong SO, Lee EJC:A prospective randomized comparison of single versus multi-dosegentamicin in the treatment of CAPD peritonitis.Perit Dial Int 10 3: S30, 1995 Google Scholar 28 Vas SI:Microbiologic aspects of chronic ambulatoryperitoneal dialysis.Kidney Int 10: 83 92, 1983 10.1038/ki.1983.15 Web of Science®Google Scholar 29 Centers for Disease Control: Nosocomial enterococci resistantto vancomycin. United States, 1989–1993. MMWR 10: 597 599, 1993 Google Scholar 30 Noble WC, Virani Z, Cree R:Co-transfer of vancomycin andother resistance genes fromEnterococcus fecalis NCTC12201to Staphylococcus aureus. FEMS Microbiol Lett 10: 195 8, 1992 10.1111/j.1574-6968.1992.tb05089.x Web of Science®Google Scholar 31 Edmond MB, Wenzel RP, Pascule AW:Vancomycin resistantStaphylococcus aureus: Perspectives on measures needed forcontrol.Ann Int Med 10: 329 34, 1996 10.7326/0003-4819-124-3-199602010-00008 Web of Science®Google Scholar 32 US Congress Office of Technology Assessment. Impacts of Antibiotic-Resistant Bacteria. OTA-H-629, Washington DC, USGovernment Printing Office, 1995 Google Scholar 33 Centers for Disease Control: Recommendations for preventingthe spread of vancomycin resistance: Recommendations of theHospital Infection Control Practices Advisory Committee (HICPAC).MMWR 44(No. RR-12), 1995 Google Scholar 34 Vas SI & Conly J. A vancomycin resistant Enterococcus faeciumoutbreak in a renal unit: Epidemiology and implications for the useof Vancomycin.Perit Dial Int 10 3: S46, 1996 Google Scholar 35 Troidle L, Kliger AS, Gorban-Brennan N, Fikrig M, Golden M, Finkelstein FO. Nine episodes of CPD-associated peritonotis withvancomycin resistant enterococci.Kidney Int 10: 1368 1372, 1996 10.1038/ki.1996.451 Web of Science®Google Scholar 36 Kiernan-Troidle L, Gorban-Brennan N, Kliger AS, Finkelstein FO:Vancomycin resistant enterococci (VRE) peritonitis.Perit Dial Int 10 3: S41, 1996 Google Scholar 37 Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Huang CC, Kawaguchi Y, Piraino B, Riella M, Schaefer F, Vas S:Peritoneal dialysis-related peritonitistreatment recommendations: 1996 updatePerit Dial Int 10: 557 573, 1996 Web of Science®Google Scholar 38 Wilson MC, Hayward RSA, Tunis SR, Bass EB, Guyatt G:User's guidelines to medical literature: VIII.How to use clinicalpractice guidelines.JAMA 10: 1630 1632, 1995 CASWeb of Science®Google Scholar Citing Literature Volume10, Issue3May 1997Pages 142-144 ReferencesRelatedInformation
Referência(s)